RESUMEN
BACKGROUND: Iohexol clearance is an accurate and precise exogenous marker of glomerular filtration rate (GFR), but protocols are generally lengthy or require multiple sampling. Shorter or simpler protocols would be more practicable. METHODS: Two clearance estimates, two weeks apart, were undertaken in 11 healthy individuals and 26 diabetic patients with minimal to moderate renal impairment (chronic kidney disease stages 1-3). Blood specimens withdrawn at 60, 90, 120, 150, 180 and 240 min post-iohexol were analysed for iohexol. RESULTS: Visit 1 demonstrated excellent correlation with visit 2 (slope 1.00, confidence interval [CI] 0.88 to 1.13, intercept 0.94 mL/min/1.73 m(2), CI -9.9 to 11.8, P=0.43). The within-individual coefficient of variation (CV) of the 240 min reference method was 5.4% at a mean GFR of 84.1 mL/min/1.73 m(2). Single point estimates between 120 and 240 min had CVs of 4.5-7.0%, and did not differ from the reference method CV by more than 2.0 mL/min/1.73 m(2). Two and three point estimates in the interval 60-120 min post iohexol injection offered no advantages over these single-point estimates and overestimated at lower GFRs. CONCLUSIONS: An iohexol clearance estimate of GFR derived from a single sample taken between 2 to 4 h after infusion may provide a suitable tool for routine clinical use.
Asunto(s)
Medios de Contraste , Diabetes Mellitus Tipo 1/fisiopatología , Tasa de Filtración Glomerular/fisiología , Yohexol , Fallo Renal Crónico/fisiopatología , Riñón/fisiopatología , Adulto , Anciano , Femenino , Humanos , Inyecciones Intravenosas , Pruebas de Función Renal , Masculino , Tasa de Depuración Metabólica , Persona de Mediana EdadRESUMEN
OBJECTIVE-Assessment and follow-up of early renal dysfunction is important in diabetic nephropathy. Plasma creatinine is insensitive for a glomerular filtration rate (GFR) >50 ml/min and creatinine clearance is unwieldy and subject to collection inaccuracies. We aimed to assess the reproducibility, reliability, and accuracy of plasma cystatin C as a measure of GFR ranging from normal to moderate impairment due to type 1 diabetes in the presence of a normal plasma creatinine concentration. RESEARCH DESIGN AND METHODS-A sensitive immunoturbidimetric cystatin C assay was examined in 29 subjects with type 1 diabetes and 11 nondiabetic subjects. Duplicate measurements of the following were collected from each subject, 2 weeks apart: cystatin C, enzymatic plasma creatinine, 24-h creatinine clearance, GFR estimated from plasma creatinine by the Cockcroft-Gault equation, and iohexol clearance as a gold standard. RESULTS-Iohexol clearance ranged from 35 to 132 ml. min(-1). 1.73 m(-2). Plasma cystatin C compared well with the other clinically used tests. The reliability of cystatin C, as assessed by the discriminant ratio, was superior to creatinine clearance (3.4 vs. 1.5, P < 0.001) and the correlation of cystatin C with iohexol clearance (Rs -0.80) was similar to that of creatinine clearance (Rs -0.74) and superior to that of plasma creatinine and the Cockcroft-Gault estimate (Rs -0.54 and 0.66, respectively). Duplicate estimations were used to provide an unbiased equation to convert plasma cystatin C to GFR. CONCLUSIONS-Based on this study, cystatin C is a more reliable measure of GFR than creatinine clearance, is more highly correlated with iohexol clearance than plasma creatinine, and is worthy of further investigation as a clinical measure of GFR in type 1 diabetes.
Asunto(s)
Cistatinas/análisis , Diabetes Mellitus Tipo 1/fisiopatología , Tasa de Filtración Glomerular , Adulto , Biomarcadores/sangre , Medios de Contraste , Creatinina/metabolismo , Cistatina C , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/orina , Femenino , Hemoglobina Glucada/análisis , Humanos , Yohexol/farmacocinética , Masculino , Tasa de Depuración Metabólica , Persona de Mediana Edad , Valores de Referencia , Análisis de Regresión , Reproducibilidad de los ResultadosRESUMEN
An immunoturbidimetric assay for cystatin C was optimized with respect to assay imprecision. After investigating the optimum pH, polyethylene glycol concentration and specimen volume, two modifications were introduced: an increase in specimen volume to 25 microL; and an extension of the pre-incubation period to 240 s. These modifications produced an assay with between-batch imprecision (coefficient of variation, n = 10 or 11) ranging from 3-9% at 0.72 mg/L to 1.3% at 5.29 mg/L. The assay was susceptible to interference from lipaemia and haemolysis but not bilirubinaemia in both the original and modified protocol. Extending the pre-incubation to 240 s improved tolerance to common interferences and retained assay applicability in the routine clinical setting.
Asunto(s)
Equilibrio Ácido-Base/inmunología , Cistatinas/análisis , Nefelometría y Turbidimetría/métodos , Bilirrubina/análisis , Bilirrubina/sangre , Creatinina/análisis , Creatinina/sangre , Cistatina C , Cistatinas/sangre , Cistatinas/química , Humanos , Concentración de Iones de Hidrógeno , Inmunoensayo/métodos , Inmunoglobulina A/análisis , Inmunoglobulina A/sangre , Inmunoglobulina A/inmunología , Técnicas In Vitro , Cinética , Polietilenglicoles/química , Juego de Reactivos para Diagnóstico , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Temperatura , Factores de Tiempo , Triglicéridos/análisis , Triglicéridos/sangre , Macroglobulinemia de Waldenström/sangre , Macroglobulinemia de Waldenström/inmunologíaRESUMEN
BACKGROUND: Kaiser Permanente-Southern California Region carried out an external benchmarking project to improve appointment access. This article provides practical guidelines for planning a benchmark project around a complex issue such as appointment access. METHOD: Before conducting external site visits, team members determined the goals of the project, defined internal processes, and identified 16 key elements of access (or those factors important to member satisfaction with appointment access). Once a questionnaire was finalized, external benchmark partners were identified and on-site visits conducted. CONCLUSION: On the basis of the on-site visits, team members identified innovative and best practices for each of the 16 key elements of access. Based on these recommendations, some improvements were made across the Southern California region, such as the elimination of provisional booking. Reports of the results have also been sent to Kaiser Permanente medical centers in the region and across the country. Each medical center is encouraged to use these results to internally improve its own appointment access.
Asunto(s)
Citas y Horarios , Accesibilidad a los Servicios de Salud/normas , Sistemas Multiinstitucionales/normas , Gestión de la Calidad Total/organización & administración , California , Sistemas de Apoyo a Decisiones Administrativas , Asignación de Recursos para la Atención de Salud , Objetivos Organizacionales , Satisfacción del Paciente , Desarrollo de Programa/métodos , Estándares de Referencia , Encuestas y CuestionariosRESUMEN
The present study examined behavioral parameters such as parent management of encopresis and parental coping styles (active, cognitive, and avoidance) as predictors of success with medical management of encopresis. The results suggest that parents use a variety of management strategies and treatment success cannot be predicted using these variables. However, in line with previous research the presence of child behavior problems appeared to be a potential predictor variable.